Staff Breadcrumb Home Staff Show filterHide filter All research areas All research areasCommunity-Acquired Infections at Mucosal InterfacesHepatitisHIVInfections of the Immunocompromised HostHealthcare-Associated InfectionsMalaria and Neglected Tropical DiseasesEmerging InfectionsNovel AntibioticsTuberculosis Partner Sites All locationsHamburg - Lübeck - Borstel - RiemsHannover - BraunschweigBonn - KölnGießen - Marburg - LangenHeidelbergTübingenMünchenAssoziierter Partner All infrastructures All infrastructuresBioresources, Biodata and Digital HealthDZIF AcademyClinical Trial UnitProduct Development A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Show all Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) Dr. Susanne Kirsch-Dahmen Project Manager Novel Antibiotics Paul-Ehrlich-Institut Dr. Nadine Kirsch-Stefan Chief OSRA University Hospital Tübingen Dr. Monica Klaeren University of Bonn Dr. Ute Klarmann-Schulz Group Leader Ludwig-Maximilians-Universität München Prof. Dr. Dr. Christoph Klein University Hospital Cologne Prof. Dr. Florian Klein Coordinator Bridging Topic "Antibody-Based Therapies" Heidelberg University Hospital Dr. Isabel Klein Project Manager Biobanking Tissue Helmholtz Centre for Infection Research Dr. Carolina J. Klett-Tammen University of Cologne Dr. Alexander Klimka Research Group Leader Technical University of Munich Prof. Dr. Percy Knolle Pagination Previous page < Return Seite 15 Seite 16 Seite 17 Seite 18 Current page 19 Seite 20 Seite 21 Seite 22 Seite 23 Seite 15 Seite 16 Seite 17 Seite 18 Seite 19 Seite 20 Seite 21 Seite 22 Seite 23 Next page Further >
Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) Dr. Susanne Kirsch-Dahmen Project Manager Novel Antibiotics
University Hospital Cologne Prof. Dr. Florian Klein Coordinator Bridging Topic "Antibody-Based Therapies"
